Retinoblastoma Binding Protein 8 anticorps (Center)
L’anticorps Lapin Polyclonal anti-Retinoblastoma Binding Protein 8 a été validé pour WB et EIA. Il convient pour détecter Retinoblastoma Binding Protein 8 dans des échantillons de Humain, Souris et Rat.
RBBP8
Reactivité: Humain
WB
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Concentration
1.0 mg/mL
Buffer
PBS containing 0.02 % sodium azide
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation
Avoid repeated freezing and thawing.
Stock
-20 °C
Stockage commentaire
Store the antibody (in aliquots) at -20 °C.
Antigène
Retinoblastoma Binding Protein 8 (RBBP8)
Autre désignation
RBBP8
Sujet
RBBP8, also known as CtBP (carboxy-terminal binding protein) interacting protein (CTIP), was characterized for its role in transcription as a cofactor for the transcriptional repressor CtBP, and also as a binding partner for other proteins including the cell cycle regulators retinoblastoma protein (Rb) and breast cancer 1 (BRCA1). It is ubiquitously expressed and localizes to the nucleus. RBBP8 is thought to modulate the functions in cell proliferation, transcriptional regulation and DNA repair. RBBP8 also plays a central role in the cell cycle checkpoint response to DNA double-stranded breaks (DSBs), with new evidence demonstrating that it controls the choice of DSB repair pathway.Synonyms: CTIP, CtBP-interacting protein, RBBP-8, Retinoblastoma-binding protein 8, Retinoblastoma-interacting protein and myosin-like